3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow pH Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects PHP-303, Placebo - Otherwise Healthy Overweight or Obese | Phase 1 | Completed | pH Pharma | 50 | 2018-12-17 | 2020-04-13 |
| A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects PHP-303, Placebo - Healthy Volunteer | Phase 1 | Completed | pH Pharma | 49 | 2018-08-02 | 2020-04-13 |
| PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects PHP-201 0.5% ophthalmic solution (topical eye drop) - Healthy Volunteer | Phase 1 | Completed | pH Pharma | 24 | 2018-02-04 | 2018-07-16 |
Obesity (1)
Ophthalmic Solutions (1) · sovesudil (1)
United States (2) · South Korea (1)
Andrew Nicholls, MD, PhD (1) · Brian Roberts, MD (1) · Soojin Kim (1)